The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Abstract
Objective. —To determine the relationship of brain infarction to the clinical expression of Alzheimer disease (AD). Design. —Cognitive function and the prevalence of dementia were determined for participants in the Nun Study who later died. At autopsy, lacunar and larger brain infarcts were identified, and senile plaques and neurofibrillary tangles in the neocortex were quantitated. Participants with abundant senile plaques and some neurofibrillary tangles in the neocortex were classified as having met the neuropathologic criteria for AD. Setting. —Convents in the Midwestern, Eastern, and Southern United States. Participants. —A total of 102 college-educated women aged 76 to 100 years. Main Outcome Measures. —Cognitive function assessed by standard tests and dementia and AD assessed by clinical and neuropathologic criteria. Results. —Among 61 participants who met the neuropathologic criteria for AD, those with brain infarcts had poorer cognitive function and a higher prevalence of dementia than those without infarcts. Participants with lacunar infarcts in the basal ganglia, thalamus, or deep white matter had an especially high prevalence of dementia, compared with those without infarcts (the odds ratio [OR] for dementia was 20.7,95% confidence interval [95% CI], 1.5-288.0). Fewer neuropathologic lesions of AD appeared to result in dementia in those with lacunar infarcts in the basal ganglia, thalamus, or deep white matter than in those without infarcts. In contrast, among 41 participants who did not meet the neuropathologic criteria for AD, brain infarcts were only weakly associated with poor cognitive function and dementia. Among all 102 participants, atherosclerosis of the circle of Willis was strongly associated with lacunar and large brain infarcts. Conclusion. —These findings suggest that cerebrovascular disease may play an important role in determining the presence and severity of the clinical symptoms of AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Population-autopsy series verified the high frequency and pathogenetic importance of combined Alzheimer disease and vascular disease in the expression of dementia as mentioned previously.”
In the citing paper
“Furthermore, vascular lesions can lower the threshold for the clinical manifestation of Alzheimer disease.”
In the citing paper
“Several studies have found that in patients with Alzheimer disease and cerebrovascular disease, less Alzheimer disease pathology is needed to express the dementia syndrome.”
In the citing paper
“typically are accompanied by Alzheimer disease and other pathologies.”
In the citing paper
“Infarcts frequently coexist with Alzheimer disease pathology in the brains of older people.”
In the citing paper
“One study showed that only people with Alzheimer disease pathology with subcortical infarcts had dementia, raising the possibility of an interaction (a multiplicative effect) between the 2 pathologies.”
In the citing paper
“It is now accepted that many of the traditional risk factors for stroke are also risk markers for Alzheimer disease and VCI.16,31,340,484–491”
In the citing paper
“Lacunes are frequently seen on imaging in elderly patients with no symptoms”
From Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration (2013) · cites this paper as [25]
In the citing paper
“are associated with an increased risk of stroke, gait impairment, and dementia.”
From Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration (2013) · cites this paper as [25]
In the citing paper
“Cerebrovascular effects of APOE4 are associated with AD, stroke, and brain hemorrhage (314, 506, 549, 614, 693).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [549]
In the citing paper
“Classical anatomic locations for strategic infarcts include the thalamus, angular gyrus, and basal ganglia, including the caudate nucleus and globus pallidus. 52-57”
From Vascular Cognitive Impairment (2017) · cites this paper as [56]
In the citing paper
“A single small infarct may cause severe cognitive deficits when located in a strategic brain region.”
From Vascular Cognitive Impairment (2017) · cites this paper as [56]
In the citing paper
“However, vascular brain lesions lower the threshold of AD pathology required to induce dementia. 56,100-102”
From Vascular Cognitive Impairment (2017) · cites this paper as [56]
In the citing paper
“Earlier studies have suggested a multiplicative effect between vascular and AD-type pathology on cognitive decline, 56 whereas recent studies indicate that the effects are additive. 49,100,105”
From Vascular Cognitive Impairment (2017) · cites this paper as [56]
In the citing paper
“many older individuals with dementia suffer from a combination of vascular and Alzheimer-type pathology with an additive effect on cognition,19”
From Diagnostic Criteria for Vascular Cognitive Disorders: A VASCOG Statement (2014) · cites this paper as [19]
In the citing paper
“On the other hand, in older individuals with moderate AD pathology subcortical vascular lesions are a major determinant of the expression of the dementia (Esiri et al., 1999; Schneider et al., 2007b; Snowdon et al., 1997).”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Snowdon et al., 1997
In the citing paper
“it seems reasonable to postulate that insulin resistance and T2D could increase AD risk through cerebrovascular disease, a factor increasingly accepted to be important in AD manifestation [5, 19-21].”
From Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial (2016) · cites this paper as [5]
Citations
Cites
The publisher hasn’t deposited this paper’s reference list.
Cited by
Sorted by citations
Items 601–700 of 1,644
Sorensen, E. P., Sarnak, M. J., Tighiouart, H., Scott, T. M., Giang, L. M., Kirkpatrick, B., Lou, K. V., & Weiner, D. E. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.12.029 · Cited by 63
Absence of cholinergic deficits in “pure” vascular dementia
Perry, E. K., Ziabreva, I., Perry, R., Aarsland, D., & Ballard, C. G. (2005) · Neurology · doi:10.1212/01.wnl.0000148591.63727.80 · Cited by 63
Amyloid and lipids in the pathology of Alzheimer disease
Roher, A. E., Kuo, Y., Kokjohn, K., Emmerling, M. R., & Gracon, S. I. (1999) · Amyloid · doi:10.3109/13506129909007315 · Cited by 63
Libon, D. J., Price, C. C., Giovannetti, T., Swenson, R., Bettcher, B. M., Heilman, K. M., & Pennisi, A. (2008) · Stroke · doi:10.1161/strokeaha.107.489997 · Cited by 62
Gorelick, P. B. (2005) · Stroke · doi:10.1161/01.str.0000158916.59742.7c · Cited by 62
Cognitive Decline and Dementia in the Oldest-Old
Kravitz, E., Schmeidler, J., & Beeri, M. S. (2012) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10092 · Cited by 65
Cognitive Function and Apolipoprotein E in Very Old Adults: Findings From the Nun Study
Riley, K. P., Snowdon, D. A., Saunders, A. M., Roses, A. D., Mortimer, J. A., & Nanayakkara, N. (2000) · The Journals of Gerontology Series B · doi:10.1093/geronb/55.2.s69 · Cited by 63
Self-citationCholesterol at the crossroads: Alzheimer's disease and lipid metabolism
Wellington, C. L. (2004) · Clinical Genetics · doi:10.1111/j.0009-9163.2004.00280.x · Cited by 63
Alzheimer’s disease and Alzheimer’s dementia: distinct but overlapping entities
Blass, J. P. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00036-2 · Cited by 62
The depressor axis of the renin–angiotensin system and brain disorders: a translational approach
Gironacci, M. M., Vicario, A., Cerezo, G., & Silva, M. G. (2018) · Clinical Science · doi:10.1042/cs20180189 · Cited by 60
Nasal Microbiota, Olfactory Health, Neurological Disorders and Aging—A Review
Thangaleela, S., Sivamaruthi, B. S., Kesika, P., Bharathi, M., & Chaiyasut, C. (2022) · Microorganisms · doi:10.3390/microorganisms10071405 · Cited by 65
Zetzsche, T., Rujescu, D., Hardy, J., & Hampel, H. J. (2010) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.10.48 · Cited by 63
Babiloni, C., Frisoni, G. B., Pievani, M., Vecchio, F., Infarinato, F., Geroldi, C., Salinari, S., Ferri, R., Fracassi, C., Eusebi, F., et al. (2007) · Human Brain Mapping · doi:10.1002/hbm.20467 · Cited by 60
Visit-to-Visit Blood Pressure Variability and Alzheimer’s Disease: Links and Risks
Nagai, M., Dote, K., Kato, M., Sasaki, S., Oda, N., Kagawa, E., Nakano, Y., Yamane, A., Higashihara, T., Miyauchi, S., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161172 · Cited by 59
Apolipoprotein E ε2 Allele and Risk of Stroke in the Older Population
Ferrucci, L., Guralnik, J. M., Pahor, M., Harris, T. B., Corti, M.-C., Hyman, B. T., Wallace, R. B., & Havlik, R. J. (1997) · Stroke · doi:10.1161/01.str.28.12.2410 · Cited by 61
Association between atherosclerosis and Alzheimer's disease: A systematic review and meta‐analysis
Xie, B., Shi, X., Xing, Y., & Tang, Y. (2020) · Brain and Behavior · doi:10.1002/brb3.1601 · Cited by 62
Cerebrovascular risk factors and preclinical memory decline in healthy APOE ε4 homozygotes
Caselli, R. J., Dueck, A. C., Locke, D. E. C., Sabbagh, M. N., Ahern, G. L., Rapcsak, S. Z., Baxter, L. C., Yaari, R., Woodruff, B. K., Hoffman‐Snyder, C., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318211c3ae · Cited by 59
PET imaging in the differential diagnosis of vascular dementia
Heiss, W., & Zimmermann‐Meinzingen, S. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.09.023 · Cited by 59
Richards, S. S., Emsley, C. L., Roberts, J., Murray, M. D., Hall, K. S., Gao, S., & Hendrie, H. C. (2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb04777.x · Cited by 59
Vascular pathology and pathogenesis of cognitive impairment and dementia in older adults
Agrawal, S., & Schneider, J. A. (2022) · Cerebral Circulation - Cognition and Behavior · doi:10.1016/j.cccb.2022.100148 · Cited by 61
Wermke, M., Sorg, C., Wohlschläger, A. M., & Drzezga, A. E. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0698-5 · Cited by 59
Sarro, L., Tosakulwong, N., Schwarz, C. G., Graff‐Radford, J., Przybelski, S. A., Lesnick, T. G., Zuk, S. M., Reid, R. I., Raman, M. R., Boeve, B. F., et al. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.07.003 · Cited by 62
Cytochrome P450 eicosanoids in cerebrovascular function and disease
Davis, C. M., Liu, X., & Alkayed, N. J. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.05.004 · Cited by 58
White-matter vascular lesions correlate with alpha EEG sources in mild cognitive impairment
Babiloni, C., Frisoni, G. B., Pievani, M., Toscano, L., Percio, C. D., Geroldi, C., Eusebi, F., Miniussi, C., & Rossini, P. M. (2008) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2008.03.021 · Cited by 57
The Effect of APOE-ε4 on Dementia is Mediated by Alzheimer Neuropathology
Mortimer, J. A., Snowdon, D. A., & Markesbery, W. R. (2009) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318190a855 · Cited by 56
Self-citationHypertension and Related Factors in the Etiology of Alzheimer's Disease
Skoog, I. G., & Gustafson, D. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04796.x · Cited by 58
Geriatric syndromes—vascular disorders?
Strandberg, T. E., Pitkälä, K. H., Tilvis, R. S., O’Neill, D. J., & Erkinjuntti, T. J. (2012) · Annals of Medicine · doi:10.3109/07853890.2012.727022 · Cited by 58
Alexander, L. D., Black, S. E., Gao, F., Szilagyi, G. M., Danells, C. J., & McIlroy, W. E. (2010) · Behavioral and Brain Functions · doi:10.1186/1744-9081-6-6 · Cited by 57
Management of acute ischaemic stroke in patients with dementia
Šubic, A., Čermáková, P., Norrving, B. G., Winblad, B. G., von Euler, M., Kramberger, M. G., Eriksdotter, M., & Ptacek, S. G. (2017) · Journal of Internal Medicine · doi:10.1111/joim.12588 · Cited by 58
MRI-based evaluation of structural degeneration in the ageing brain: Pathophysiology and assessment
Grajauskas, L. A., Siu, W. W. Y., Medvedev, G., Guo, H., D’Arcy, R. C. N., & Song, X. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.11.004 · Cited by 61
Classification and Subtypes of Vascular Dementia
Wallin, A., Milos, V., Sjögren, M. J. C., Pantoni, L., & Erkinjuntti, T. (2003) · International Psychogeriatrics · doi:10.1017/s1041610203008937 · Cited by 56
Vascular dementia: diagnosis, management and possible prevention
Sachdev, P. S., Brodaty, H., & Looi, J. C. (1999) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1999.tb126889.x · Cited by 57
Vascular cognitive impairment: epidemiology, subtypes, diagnosis and management
Black, S. E. (2011) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.4997/jrcpe.2011.121 · Cited by 61
Kitazume, S., Yoshihisa, A., Yamaki, T., Oikawa, M., Tachida, Y., Ogawa, K., Imamaki, R., Hagiwara, Y., Kinoshita, N., Takeishi, Y., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.398578 · Cited by 58
Age-associated leukoaraiosis and cortical cholinergic deafferentation
Bohnen, N. I., Müller, M. L. T. M., Kuwabara, H., Constantine, G. M., & Studenski, S. A. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a187c6 · Cited by 55
Early Diagnosis of Alzheimer’s Disease
Daffner, K. R., & Scinto, L. F. M. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-005-6_1 · Cited by 56
Cerebral Small Vessel Disease in Sporadic and Familial Alzheimer Disease
Kalaria, R. N., & Falla, D. S. (2021) · American Journal Of Pathology · doi:10.1016/j.ajpath.2021.07.004 · Cited by 56
Outcomes After Stroke: Risk of Recurrent Ischemic Stroke and Other Events
Elkind, M. S. V. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.02.005 · Cited by 56
Baroreflex function is reduced in Alzheimer’s disease: a candidate biomarker?
den Abeelen, A. S. S. M.-V., Lagró, J., Gommer, E. D., Reulen, J. P. H., & Claassen, J. A. H. R. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.10.010 · Cited by 57
Polidori, M. C., Marvardi, M., Cherubini, A., Senin, U., & Mecocci, P. (2001) · Aging Clinical and Experimental Research · doi:10.1007/bf03351481 · Cited by 56
Gain in Brain Immunity in the Oldest-Old Differentiates Cognitively Normal from Demented Individuals
Katsel, P., Tan, W., & Haroutunian, V. H. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007642 · Cited by 57
Kelly, P., Denver, P., Satchell, S. C., Ackermann, M., Konerding, M. A., & Mitchell, C. A. (2017) · Angiogenesis · doi:10.1007/s10456-017-9568-3 · Cited by 56
CSF sTREM2 in delirium—relation to Alzheimer’s disease CSF biomarkers Aβ42, t-tau and p-tau
Henjum, K., Quist‐Paulsen, E., Zetterberg, H., Blennow, K., Nilsson, L. N. G., & Watne, L. O. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1331-1 · Cited by 56
Comparability of the Clinical Diagnostic Criteria for Vascular Dementia: A Critical Review. Part I
Wiederkehr, S., Simard, M., Fortin, C., & van Reekum, R. (2008) · Journal of Neuropsychiatry · doi:10.1176/jnp.2008.20.2.150 · Cited by 56
Molecular pathogenesis of sporadic and familial forms of Alzheimer's disease
Ray, W. J., Ashall, F., & Goate, A. (1998) · Molecular Medicine Today · doi:10.1016/s1357-4310(98)01229-5 · Cited by 55
Kim, C. M., Alvarado, R. L., Stephens, K. A., Wey, H., Wang, D. J. J., Leritz, E. C., & Salat, D. H. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.10.023 · Cited by 54
An inverse association of cardiovascular risk and frontal lobe glucose metabolism
Kuczynski, B., Jagust, W. J., Chui, H. C., & Reed, B. (2009) · Neurology · doi:10.1212/01.wnl.0000343005.35498.e5 · Cited by 55
Paraoxonase 1 192/55 Gene Polymorphisms in Alzheimer's Disease
DANTOINE, T. F., Drouet, M., Debord, J., Merle, L., Cogné, M., & Charmes, J. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04821.x · Cited by 54
Vascular cognitive impairment: Modeling a critical neurologic disease in vitro and in vivo
Helman, A. M., & Murphy, M. P. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.12.009 · Cited by 55
Vascular and Metabolic Factors in Alzheimer’s Disease and Related Dementias: Introduction
Iadecola, C. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0319-y · Cited by 59
Neuropathology of cerebrovascular diseases
Ferrer, I., & Vidal, N. (2017) · Handbook of clinical neurology · doi:10.1016/b978-0-12-802395-2.00007-9 · Cited by 55
de la Monte, S. M., Sohn, Y. K., ETIENNE, D., Kraft, J., & Wands, J. R. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06351.x · Cited by 54
Donepezil for vascular cognitive impairment
Malouf, R. S., & Birks, J. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004395 · Cited by 54
Alzheimer's disease with and without cerebral infarcts
del Ser, T., Hachinski, V., Merskey, H., & Muñoz, D. G. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.08.016 · Cited by 53
Capillary beds are decreased in Alzheimer's disease, but not in Binswanger's disease
Kitaguchi, H., Ihara, M., Saiki, H., Takahashi, R., & Tomimoto, H. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.02.021 · Cited by 53
. Pittsburgh compound B binding in poststroke dementia.
Mok, V., Leung, E. Y. L., Chu, W., Chen, S., Wong, A., Xiong, Y., Lam, W., Ho, C. L., & Wong, K. S. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.12.014 · Cited by 52
Li, M., Kitamura, A., Beverley, J., Koudelka, J., Duncombe, J., Lennen, R. J., Jansen, M. A., Marshall, I., Platt, B., Wiegand, U. K., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.788519 · Cited by 55
Can Stroke Cause Neurodegenerative Dementia?
Cumming, T. B., & Brodtmann, A. G. (2011) · International Journal of Stroke · doi:10.1111/j.1747-4949.2011.00666.x · Cited by 55
Comorbid Aβ toxicity and stroke: hippocampal atrophy, pathology, and cognitive deficit
Amtul, Z., Nikolova, S., Gao, L., Keeley, R. J., Bechberger, J. F., Fisher, A. L., Bartha, R., Muñoz, D. G., McDonald, R. J., Naus, C. C. G., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.01.005 · Cited by 51
The association of diabetes and dementia and possible implications for nondiabetic populations
Ravona‐Springer, R., & Beeri, M. S. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.152 · Cited by 55
Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid
Selnes, P., Blennow, K., Zetterberg, H., Grambaitė, R., Rosengren, L., Johnsen, L., Stenset, V. T. V., & Fladby, T. (2010) · Cerebrospinal Fluid Research · doi:10.1186/1743-8454-7-10 · Cited by 52
Risk factors for incident Alzheimer's disease in African Americans and Yoruba
Ogunniyi, A. O., Hall, K. S., Gureje, O., Baiyewu, O., Gao, S., Unverzagt, F. W., Smith‐Gamble, V., Evans, R. M., Dickens, J., Musick, B. S., et al. (2006) · Metabolic Brain Disease · doi:10.1007/s11011-006-9017-2 · Cited by 52
Duara, R., Loewenstein, D., Greig, M. T., Acevedo, A., Potter, E. L., Appel, J., Raj, A., Schinka, J. A., Schofield, E., Barker, W., et al. (2010) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181c534a0 · Cited by 52
Jagust, W. J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07230-0 · Cited by 52
Assessment of Suspected Dementia
Chertkow, H. M., Bergman, H., Schipper, H. M., Clarfield, A. M., Gauthier, S. G., Fontaine, S., & Bouchard, R. W. (2001) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100001189 · Cited by 52
Vitamin B12, folate, homocysteine and dementia: are they really related?
Arioğul, S., Cankurtaran, M., Dağli, N., Khalil, M., & Yavuz, B. (2005) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2004.07.005 · Cited by 51
Ihl, R. (2013) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2013.814796 · Cited by 50
Depressive symptoms predict longitudinal change in executive control but not memory
Royall, D. R., Palmer, R., Chiodo, L. K., & Polk, M. J. (2011) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2697 · Cited by 51
Ankolekar, S., Renton, C., Sare, G. M., Ellender, S., Sprigg, N., Wardlaw, J. M., & Bath, P. M. (2014) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2014.04.022 · Cited by 53
Cerebral hemodynamics of the aging brain: risk of Alzheimer disease and benefit of aerobic exercise
Tarumi, T., & Zhang, R. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00006 · Cited by 59
Drug Repositioning: An Opportunity to Develop Novel Treatments for Alzheimer’s Disease
Corbett, A., Williams, G. H., & Ballard, C. G. (2013) · Pharmaceuticals · doi:10.3390/ph6101304 · Cited by 50
Bubu, O. M., Umasabor‐Bubu, O. Q., Turner, A. D., Parekh, A., Mullins, A. E., Kam, K., Birckbichler, M. K., Mukhtar, F., Mbah, A. K., Williams, N. J., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12184 · Cited by 57
Whyte, E. M., Mulsant, B. H., Butters, M. A., Qayyum, M., Towers, A. L., Sweet, R. A., Klunk, W. E., Wisniewski, S. R., & DeKosky, S. T. (2002) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200205000-00012 · Cited by 50
Babiloni, C., Frisoni, G. B., Vecchio, F., Lizio, R., Pievani, M., Geroldi, C., Fracassi, C., Vernieri, F., Rodriguez, G., Nobili, F. M., et al. (2010) · Human Brain Mapping · doi:10.1002/hbm.21157 · Cited by 50
The C677T Mutation in the Methylenetetrahydrofolate Reductase (MTHFR) Gene and Vascular Dementia
Pollak, R. D., Pollak, A., Idelson, M., Bejarano‐Achache, I., Doron, D., & Blumenfeld, A. (2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb04725.x · Cited by 50
Alzheimer Disease as a Vascular Disorder: Nosological Evidence
Royall, D. R. (2002) · Stroke · doi:10.1161/01.str.0000028987.97497.22 · Cited by 53
Hung, V., Yeung, P. K. K., Lai, A. K. W., Ho, M. C., Lo, A., Chan, K. C., Wu, E. X., Chung, S. S., Cheung, C. W., & Chung, S. K. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.109 · Cited by 51
Huang, K., Lin, K., Ho, M.-Y., Chang, Y.-J., Chang, C.-H., Wey, S., Hsieh, C., Yen, T., Hsiao, I., & Lee, T. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.04.014 · Cited by 51
Framingham risk score can predict cognitive decline progression in Alzheimer's disease
Viticchi, G., Falsetti, L., Buratti, L., Boria, C., Luzzi, S., Bartolini, M., Provinciali, L., & Silvestrini, M. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.07.023 · Cited by 49
Pluta, R. M., Kocki, J., Ułamek-Kozioł, M., Petniak, A., Gil-Kulik, P., Januszewski, S., Bogucki, J., Jabłoński, M., Brzozowska, J., Furmaga-Jabłońska, W., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151102 · Cited by 49
Altered expression of Notch1 in Alzheimer's disease
Cho, S.-J., Yun, S., Jo, C., Jeong, J., Park, M. H., Han, C., & Koh, Y. H. (2019) · PLoS ONE · doi:10.1371/journal.pone.0224941 · Cited by 49
Dementia in developing countries. A consensus statement from the 10/66 Dementia Research Group.
Prince, M. J. (2000) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(200001)15:1 · Cited by 108
Loewenstein, D., Acevedo, A., Potter, E. L., Schinka, J. A., Raj, A., Greig, M. T., Agrón, J., Barker, W., Wu, Y., Small, B. J., et al. (2009) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181b7ef42 · Cited by 49
Epidemiology and Risk Factors for Dementia
Dintica, C. S., & Yaffe, K. S. (2022) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2022.07.011 · Cited by 56
Ischemia as a common trigger for Alzheimer’s disease
Elman-Shina, K., & Efrati, S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1012779 · Cited by 48
Risk Factors for Alzheimer’s Disease: An Epidemiological Study
Janoutová, J., Kovaľová, M., Machaczka, O., Ambrož, P., Zatloukalová, A., Němček, K., & Janout, V. (2021) · Current Alzheimer Research · doi:10.2174/1567205018666210820124135 · Cited by 49
Alzheimer disease and other dementias
Alva, G., & Potkin, S. G. (2003) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(03)00028-4 · Cited by 48
Caughlin, S., Hepburn, J. D., Park, D. H., Jurčić, K., Yeung, K. K. ‐., Cechetto, D. F., & Whitehead, S. N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130364 · Cited by 49
Kim, S., Lee, M., & Choi, Y. K. (2019) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2019.119 · Cited by 48
Diagnostic Evaluation of Elderly Patients with Mild Memory Problems
Karlawish, J. H., & Clark, C. M. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-5-200303040-00011 · Cited by 48
Stroke risk factors and loss of high cognitive function
Elkins, J. S., O’Meara, E. S., Longstreth, W. T., Carlson, M. C., Manolio, T. A., & Johnston, S. C. (2004) · Neurology · doi:10.1212/01.wnl.0000137014.36689.7f · Cited by 49
Montine, T. J., Corrada, M. M., Kawas, C. H., Bukhari, S. A., White, L. R., Tian, L., & Cholerton, B. (2022) · Neurology · doi:10.1212/wnl.0000000000200832 · Cited by 51
Epigenetic Changes in Neurodegenerative Diseases
Kwon, M. J., Kim, S., Han, M., & Lee, S. B. (2016) · Molecules and Cells · doi:10.14348/molcells.2016.0233 · Cited by 49
Energy and the Alzheimer brain
Mamelak, M. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.02.001 · Cited by 47
Balzano, T., Forteza, J., Borredá, I., Molina, P., Giner, J., Leone, P., Urios, A., Montoliu, C., & Felipo, V. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly061 · Cited by 50
Risk of Cognitive Decline in Older Patients After Carotid Endarterectomy: An Observational Study
Bo, M., Massaia, M., Speme, S., Cappa, G., Strumia, K., Cerrato, P., Ponzio, F., & Poli, L. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00787.x · Cited by 47
Intracranial artery stenosis and progression from mild cognitive impairment to Alzheimer disease
Zhu, J., Wang, Y., Li, J., Deng, J., & Zhou, H. (2014) · Neurology · doi:10.1212/wnl.0000000000000185 · Cited by 46
Vascular dementia: A diagnosis running out of time
Stewart, R. J. (2002) · The British Journal of Psychiatry · doi:10.1192/bjp.180.2.152 · Cited by 47
Pluta, R. M., Kocki, J., Ułamek-Kozioł, M., Bogucka‐Kocka, A., Gil-Kulik, P., Januszewski, S., Jabłoński, M., Petniak, A., Brzozowska, J., Bogucki, J., et al. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.08.002 · Cited by 46
BioAge: Toward a multi-determined, mechanistic account of cognitive aging
DeCarlo, C. A., Tuokko, H. A., Williams, D., Dixon, R. A., & MacDonald, S. W. S. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.09.003 · Cited by 50
Metadata
- Authors
- Snowdon, D. A.
- Corresponding author
- Snowdon, David A.
- ORCID
- Snowdon, David A.
- Venue
- JAMA: The Journal of the American Medical Association
- Publisher
- American Medical Association (AMA)
- Published
- 1997-03-12
- Volume
- 277
- Issue
- 10
- Pages
- 813
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W4296588155
- Cited by
- 1,590
- References
- 0
- Citations by year
- 2026: 23 · 2025: 31 · 2024: 30 · 2023: 39 · 2022: 43 · 2021: 42 · 2020: 51 · 2019: 57 · 2018: 52 · 2017: 60 · 2016: 74 · 2015: 63 · 2014: 71 · 2013: 61 · 2012: 74
- FWCI
- 34.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- Funders
- National Institute on Aging (R01AG009862, P50AG005144, KO4AG00553)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- Alzheimer's disease, cerebral infarction, lacunar infarction, dementia, cognitive function, amyloid plaques, neurofibrillary tangles, cerebrovascular disease, atherosclerosis, circle of Willis, thalamic infarction, basal ganglia infarcts, older women, neuropathology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
